Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
about
Relevance of tumor-infiltrating lymphocytes in breast cancerPathways and therapeutic targets in melanomaTrial Watch: Immunomodulatory monoclonal antibodies for oncological indicationsImproving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationThe Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor EfficacyAbnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata.An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling.Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanomaInvariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes.Activating and propagating polyclonal gamma delta T cells with broad specificity for malignanciesHIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunityFocusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.Effector function of CTLs is increased by irradiated colorectal tumor cells that modulate OX-40L and 4-1BBL and is reversed following dual blockade.Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell TherapyLoss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapySurrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.The use of endogenous T cells for adoptive transfer.Mitigating the toxic effects of anticancer immunotherapy.Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer.Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy.Phenotype and function of tumor-associated neutrophils and their subsets in early-stage human lung cancer.Surface engineering for lymphocyte programming.HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genesIdentification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma.Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.Continuous 4-1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapy.Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy.Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.Tumour necrosis factor receptor superfamily member 9 (TNFRSF9) is up-regulated in reactive astrocytes in human gliomas.Nanoscale artificial antigen presenting cells for cancer immunotherapy.The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.Successes and setbacks of early investigational drugs for melanoma.Anticalin® Proteins as Therapeutic Agents in Human Diseases.
P2860
Q26795598-694CEA5A-48A8-4B5F-9566-279564B2D67DQ26865736-463E78A5-15BC-4E7C-90EC-90E4710812D6Q26996518-F0CDE0A2-2FA2-406A-BFB3-F6A7F10A8A25Q28068378-42EB54A4-760A-4FBA-BB60-3B90840686B8Q28076473-5AF4B75B-94C8-4780-83F1-AB872081833CQ33617937-FA3DE759-5642-4DAA-B1D6-F70474ADB617Q33987134-DDDF6C18-4933-4D3F-A380-0F7325D776F6Q34350259-976FC410-3F15-476E-AFAC-DF52AC3CA33EQ34389948-65E8D273-3CE6-4FFF-B63F-7C50CBFBDC2BQ34517192-B25C85A5-D730-42AD-ACD2-2D14A93F77D7Q35108680-15A70AE8-2DCC-48D7-B2B8-504FC9CBD80BQ35764479-E15E3E3F-6BF4-496D-975D-FA2F170DB5FFQ35922726-DE903CF9-B5C8-4825-8FCE-F38600EBC670Q36173500-DFCD3819-8605-43BE-B6E4-2EADCF38B75FQ36553576-F00D7932-F1BE-4B75-A2DD-89D6B9AD3440Q37043492-22825416-2CDC-4F4E-A892-231A85BE686AQ37652790-2F0210A8-92A2-48EB-91E7-AB82B9C9221AQ37706835-72C2949B-C4E8-4AFE-8A9E-140890E610E4Q38170503-DEC03D36-7A90-47B9-871B-02697955A459Q38180319-4151341F-0C37-4B20-A12E-246E3D50E600Q38293525-6517F881-FB9A-4EEB-A2D8-EB9F32329CD0Q38698632-69504B69-7F18-44F1-BBD8-882F4DAF450DQ39173529-5DC6B02C-5CBF-45AB-BD02-B4785CC63A1EQ40214162-DEDDA97A-EAFE-47DE-9EDA-27EA6F0D95D6Q41633092-8CAB5DA4-BD58-4539-A0AE-EA2633DE8ADBQ42078847-9228D287-E987-43E0-8DC4-6A45D6BB3BC2Q42157682-DAFF74AB-2E96-4C3E-9332-3285C9AD20EDQ42848213-F3A88CA9-8267-422A-942E-E3210FB88E49Q43129884-FF0ED853-98E7-4DC5-8CC7-38E10393A260Q43147493-3B222AE6-B1DD-4354-8967-47A63240DDB0Q44610668-C95DCF0D-7B2A-411B-B824-D5D1E62D8240Q52662884-3274902D-A142-46BF-8F78-1FA3D9F66AE6Q52740477-82CEB9D1-1A19-4524-91C5-8362744161AAQ53838405-0E38918F-7054-4F1E-8CA9-5C30A608FAE1Q55484632-5FBB9480-5A3A-4BED-8715-258F9B8EF246
P2860
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8
@nl
Co-stimulation through 4-1BB/C ...... s for adoptive T-cell therapy.
@ast
Co-stimulation through 4-1BB/C ...... s for adoptive T-cell therapy.
@en
type
label
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8
@nl
Co-stimulation through 4-1BB/C ...... s for adoptive T-cell therapy.
@ast
Co-stimulation through 4-1BB/C ...... s for adoptive T-cell therapy.
@en
prefLabel
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8
@nl
Co-stimulation through 4-1BB/C ...... s for adoptive T-cell therapy.
@ast
Co-stimulation through 4-1BB/C ...... s for adoptive T-cell therapy.
@en
P2093
P2860
P1433
P1476
Co-stimulation through 4-1BB/C ...... s for adoptive T-cell therapy.
@en
P2093
Amod Sarnaik
Jeffrey J Molldrem
Jeffrey Weber
Jessica Ann Chacon
Laszlo Radvanyi
Pariya Sukhumalchandra
Patrick Hwu
Richard C Wu
Shari Pilon-Thomas
P2860
P304
P356
10.1371/JOURNAL.PONE.0060031
P407
P577
2013-04-01T00:00:00Z